Reuters NewMedia, Inc.; Monday December 29 11:08 AM EST
HARARE, Zimbabwe (Reuters) - Zimbabwe s Harare hospital mortuary is holding 1,200 bodies, 20 times its normal capacity, the state-owned Sunday Mail newspaper reported. The paper did not give reasons for the many bodies, but said rotting corpses were stacked on top of each other on the floor. It said relatives collectin
Reuters NewMedia, Inc.; Monday December 22, 10:10 am EST
DURHAM, N.C., Dec 22 (Reuters) - Triangle Pharmaceuticals Inc ON Monday said the government removed a clinical hold on testing of its HIV drug, DMP-450, and the company has agreed to start Phase I studies in January. We are very pleased that we have been able to rapidly reach agreement with the Food and Drug Administra
Reuters NewMedia, Inc.; Friday December 19, 11:25 am EST
Christopher Lyddon
LONDON, Dec 18 (Reuters) - A new condom, made without latex, offers relief to allergy sufferers but is unlikely to make much of a dent in demand in the multi-million dollar global rubber market, industry sources and the Latex Allergy Support Group (LASG) said on Friday. The Avanti brand of condom was recently launched
Reuters NewMedia, Inc.; Thursday December 18 2:01 AM EST
NEW YORK (Reuters) - Eighty-seven percent of young people do not believe they are vulnerable to getting the AIDS virus, according to a new study conducted by Viacom s MTV and Yale University. The study, conducted in partnership with Yale s Center for Interdisciplinary Research on AIDS, found an even higher percentage o
Reuters NewMedia, Inc.; Tuesday December 16, 6:29 pm EST
Michael Conlon
CHICAGO, Dec 16 (Reuters) - People recently infected by the AIDS virus may be identified by specific symptoms such as fever, joint pain and night sweats weeks before the most commonly used blood test confirms the diagnosis, a study published on Tuesday said. The finding could help better single out people in the very e
Reuters NewMedia, Inc.; Wednesday December 10, 9:33 am EST
NEW YORK, Dec 10 (Reuters) - An AIDS vaccine developed by CEL-SCI Corp demonstrated protection against HIV infection in animals and causes humans to produce antibodies which recognize the most prevalent subtypes of the virus, the company said Wednesday. The company s studies showed that 78 percent of test mice, injecte
Reuters NewMedia, Inc.; Tuesday December 9, 8:56 pm EST
DALLAS, Dec 9 (Reuters) - The American Medical Association , the influential group representing U.S. doctors, on Tuesday proposed that doctors be allowed to discuss with their patients the potential benefits of using marijuana to treat some diseases without risk of criminal charges. Delegates at the AMA s semi-annu
Reuters NewMedia, Inc.; Monday December 8, 1997 - 7:12 AM EST
WASHINGTON (Reuters) - A White House advisory panel charged the federal fight against AIDS had stalled in recent months in the absence of bold leadership by PresidentClinton s administration. The 32-member panel in its second progress report faulted the administration, like its predecessors, for failing to lay out a co
Reuters NewMedia, Inc.; Saturday, December 6, 1997
Matthew Bunce
ABIDJAN, Dec 7 (Reuters) - Africa tops the league for babies born with the AIDS virus and accounts for 90 percent of all new cases among children every year, according to a group monitoring the spread of the disease worldwide. The Monitoring the AIDS Pandemic (MAP) Network said a mosaic of AIDS epidemics across Africa
Reuters NewMedia, Inc.; Friday December 5 11:01 AM EST
PHNOM PENH, Cambodia (Reuters) - Cambodian premier Hun Sen on Friday ordered cable television operators to stop broadcasting sex films, saying they were counterproductive to the government s fight against AIDS. This is a public order ... the Ministry of Information must tell the owners of the cable TV companies to imme
Reuters NewMedia, Inc.; Friday December 5 8:41 AM EST
Matthew Bunce
ABIDJAN, Ivory Coast (Reuters) - Drug trials to cut the rate of mother-to-child transmission of the virus that leads to AIDS will be completed by January, leading health experts said. Trials in Thailand , Ivory Coast and elsewhere that use a short treatment of the drug
Reuters NewMedia, Inc.; Thursday December 4, 6:48 pm EST
Maggie Fox, Health and Science Correspondent
WASHINGTON, Dec 4 (Reuters) - Americans are unusually well-informed about AIDS and want the government to spend more fighting it, according to a survey released on Thursday. The nationwide survey of more than 1,200 adults, done for the Kaiser Family Foundation, also found that people think AIDS is one of the two top ma
Reuters NewMedia, Inc.; Tuesday December 2 2:56 PM EST
Maggie Fox, Health and Science Correspondent
WASHINGTON (Reuters) - Hydeia Broadbent wasn t scared to learn she had AIDS. I have a big family, she said. We were always big and bad ... If you aren t afraid of the dark you deal with it. I wasn t afraid. But Joey DiPaolo, of Staten Island, N.Y., was. I didn t know if I was going to be able to live, he told a class o
Reuters NewMedia, Inc.; Tuesday December 2 2:56 PM EST
Patricia Reaney
LONDON (Reuters) - It took Joe more than a year before he told anyone. His parents still don t know and he has no intention of telling them. Liz kept her secret for just as long, and Florence didn t find out until her partner died. Such is the stigma of being HIV positive and having AIDS that 16 years into the epidemic
Reuters NewMedia, Inc.; Tuesday December 2, 6:14 am EST
STOCKHOLM, Dec 2 (Reuters) - Pharmacia & Upjohn (PHU.ST) (P&U) said on Tuesday it had applied for registration of its anti AIDS drug Rescriptor within the European Union (EU) with the hope to have it cleared in the second quarter of next year. We have applied for registration in the EU.
Reuters NewMedia, Inc.; Tuesday December 2 9:46 AM EST
David Kushner
SAN FRANCISCO (Wired) - In honor of the 10th International World AIDS Day and Day Without Art, Internet artists and activists joined Monday to raise awareness about HIV and AIDS. Day Without Art s most ambitious interactive project was an event performance of New York s Silicon Alley-based Plaintext (http://www.sva.edu
Reuters NewMedia, Inc.; Tuesday December 2, 8:02 am EST
SALT LAKE CITY, Dec 2 (Reuters) - Medizone International Inc, a maker of a treatment for HIV/AIDS and Hepatitis B, said Tuesday it would begin an aggressive clinical trial program in Italy during the second quarter -- instead of during the first quarter as originally planned -- because of significant design changes it
Reuters NewMedia, Inc.; Monday December 1, 4:03 pm EST
Maggie Fox, Health and Science Correspondent
WASHINGTON, Dec 1 (Reuters) - The AIDS epidemic is worse than anyone feared, with the HIV virus infecting twice as many people than experts calculated and threatening to orphan more than 40 million children, experts said on Monday. Heads of the top agencies fighting AIDS, from the United Nations to the
Reuters NewMedia, Inc.; Monday December 1, 6:47 pm EST
Maggie Fox, Health and Science Correspondent
WASHINGTON, Dec 1 (Reuters) - First lady Hillary Rodham Clinton joined forces with AIDS campaigners and movie stars on Monday to urge that AIDS drugs be tested on children and be made more widely available to them. They said 25 percent of all new HIV infections in the United States were in people under age 20, and that
Reuters NewMedia, Inc.; Monday December 1 7:15 PM EST
Maggie Fox, Health and Science Correspondent
WASHINGTON (Reuters) - President Clinton Monday ordered all federal agencies to find new ways to prevent the spread of AIDS among children. In a declaration marking World AIDS Day, Clinton noted that AIDS was the sixth leading cause of death among people aged 15 to 24, and the biggest cause of death of young black Amer
Reuters NewMedia, Inc.; Monday December 1, 3:05 pm EST
BASLE, Switzerland , Dec 1 (Reuters) - Roche AG said the European Union had cleared its zalcitabine ( ddC ) nucleoside analogue therapy for the treatment of HIV/AIDS in combination with other antiretroviral therapies. The drug, called HIVID, has been a component of HIV/AIDS treatment regimens in Europe sin
Reuters NewMedia, Inc. - Friday November 28, 2:31 pm EST
Maggie Fox, Health and Science Correspondent
WASHINGTON, Nov 28 (Reuters) - It has been a sobering month for people with AIDS and the researchers trying to help them. Scientists have admitted the cocktail of drugs that originally offered hope of a cure cannot eradicate the virus, they have been told it is still too soon to try out the vaccine considered to be the
Reuters NewMedia, Inc. - Friday November 28 4:56 PM EST
MIAMI (Reuters) - Virtually all sexually active men and women are aware of the danger of the HIV virus and AIDS, and most worry about becoming infected, but almost half have not changed their sexual behavior to protect themselves, an international survey released Friday found. The French and the Mexicans worry most abo
Reuters NewMedia, Inc. - Friday November 28, 11:48 am EST
Ek Madra
PHNOM PENH, Nov 28 (Reuters) - To the soldier facing the dangers of land mines, who was only a child during the political upheaval that spawned Cambodia s 1970s killing fields, AIDS seems a remote threat. Land mines are more dangerous than AIDS. Mines blow your legs off and kill you, the 27-year-old shrugged as he swig
Reuters NewMedia, Inc. - Friday November 28 10:51 AM EST
Patricia Reaney
LONDON (Reuters) - Medical researchers said on Friday they are cautiously optimistic that a plethora of new drugs being developed could lead to an effective AIDS vaccine. As news that AIDS cases soared to 30 million worldwide hit the headlines and amid preparations for World Aids Day on Monday, doctors in Britain said
Reuters NewMedia, Inc.; Wednesday November 26, 1997 7:40 pm EST
Jason Brown
OTTAWA, Nov 26 (Reuters) - An official inquiry into a scandal over tainted blood in Canada recommended on Wednesday immediate compensation to all those involved in the worst public health disaster in the country s history. The inquiry was called more than four years ago after some 1,200 Canadians were infected with HIV
Reuters NewMedia, Inc. - Wednesday November 26 4:51 PM EST
SAO PAULO (Reuters) - Three men who broke into a Sao Paulo apartment and threatened to infect the family with the AIDS virus, made off with $45,000 in jewelry and money, police said Wednesday. The men, one of whom was carrying a gun, entered the complex Tuesday and forced a man in the elevator to take them to his apart
Reuters NewMedia, Inc. - Wednesday November 26 10:45 AM EST
Evelyn Leopold
UNITED NATIONS (Reuters) - AIDS cases soared worldwide to 30 million adults and children in 1997 with researchers saying they had grossly underestimated the rate of infection, now at about 16,000 a day. The sharp climb -- from 22.6 million people in 1996 -- is due to new methods of collecting data as well as an actual
Reuters NewMedia, Inc. - Tuesday November 25, 8:27 pm Eastern Time
Robert Melnbardis
MONTREAL, Nov 25 (Reuters) - Four bombs exploded on Tuesday at AIDS drugmaker BioChem Pharma Inc s (Toronto:BCH.TO - news) plant in Montreal and the company s headquarters, forcing evacuation of about 250 employees at the two sites, police said. No one immediately claimed responsibility for the blasts, which caused no
Reuters NewMedia, Inc. - Sunday, 23 November 1997.
Simon Denyer
NAIROBI, Nov 23 (Reuters) - It is almost impossible to predict accurately the impact of HIV and AIDS on African economies, but one thing is certain -- it is the poorest people and the poorest countries who are most at threat from the epidemic. Campaigners argue that AIDS is a serious threat to African economic growth,
Reuters NewMedia, Inc. - Thursday November 20, 7:36 pm Eastern Time
ATLANTA, Nov 20 (Reuters) - The number of U.S. babies born with AIDS has dropped by more than 40 percent in recent years because more women are using drugs that reduce the risk of passing on the virus during pregnancy, health officials said on Thursday. The Centers for Disease Control and Prevention (CDC) said the numb
Reuters NewMedia, Inc. - Thursday November 20, 8:43 pm Eastern Time
Maggie Fox, Health and Science Correspondent
WASHINGTON, Nov 20 (Reuters) - U.S. researchers said on Thursday they had found a new approach, using gene therapy, to fight the AIDS virus. They said the method might be used to ferret out some of the last reserves of the virus that lurk in immune system cells even after years of therapy with powerful drugs. The new a
Reuters NewMedia, Inc. - Thursday November 20, 7:37 pm Eastern Time
Maggie Fox, Health and Science Correspondent
WASHINGTON, Nov 20 (Reuters) - U.S. researchers said on Thursday they had found out how some people s immune systems fight off the AIDS virus and said their discovery might help efforts to formulate a vaccine. Very early treatment with a cocktail of drugs known to control the virus could give the immune system just the
Reuters NewMedia, Inc. - Wednesday November 19, 11:20 pm Eastern Time
Maggie Fox, Health and Science Correspondent
WASHINGTON, Nov 19 (Reuters) - Nearly 40 million children in developing countries stand to lose one or both parents to AIDS over the next 13 years, with catastrophic results, U.S. experts said on Wednesday. A survey by the U.S. Agency for International Development (USAID) and the Census Bureau predicted the AIDS epidem
Reuters NewMedia, Inc. - Wednesday November 19, 8:49 pm Eastern Time
BOSTON, Nov 19 (Reuters) - Evidence from a study published on Wednesday suggests that immediate treatment with the drug AZT can prevent the development of AIDS in health care workers stuck by needles or other instruments contaminated by the virus. The U.S. Public Health Service and the International AIDS Society has al
Reuters NewMedia, Inc. - Monday November 17, 2:49 am Eastern Time
BASLE, Switzerland , Nov 17 (Reuters) - Swiss pharmaceuticals group Roche Holding AG (OTC BB:ROHHY - news; ROCZg.S) said on Monday it was launching the HIV treatment drug Fortovase , a new soft gelatin form of saquinavir , in the United States
Reuters NewMedia, Inc. - Monday November 17 8:20 AM EST
David Fox
NAIROBI, Kenya (Reuters) - The United Nations will release new data next month which shows that global infections of the deadly HIV/AIDS virus have been significantly underestimated, U.N. officials said on Monday. UNAIDS , the world body s anti-AIDS taskforce, said nearly half the sexually active adult populations of s
Reuters NewMedia, Inc. - Thursday November 13 5:24 PM EST
QUEBEC CITY (Reuters) - A prototype for an invisible condom to help fight HIV and other sexually transmitted diseases was unveiled Thursday by a Canadian university that hopes to make it available in two years. Developed over seven years by Laval University s Infectious Diseases Research Center, the new condom is in fa
Reuters NewMedia, Inc. - Thursday November 13 11:31 PM EST
Maggie Fox, Health and Science Correspondent
WASHINGTON (Reuters) - AIDS experts admitted on Thursday that the cocktail of drugs now used widely to keep AIDS at bay in people infected with HIV will probably never cure them. They said tests showed the AIDS virus still lurks in the immune system cells it infects, even after years of taking the powerful drugs.
Reuters NewMedia, Inc. - Wednesday November 12 10:54 AM EST
WAKEMAN, Ohio (Reuters) - Eighteen fifth-graders who used the same needle to prick their fingers in a science experiment have been offered tests for blood-borne diseases such as AIDS, a school official said Tuesday. The classroom experiment three weeks ago at Western Reserve Middle School in nearby Collins was designed
Reuters NewMedia, Inc. - Friday November 7 6:08 PM EST
WASHINGTON, Nov 7 (Reuters) - The U.S. Food and Drug Administration on Friday approved Hoffman-La Roche s Fortovase ( saquinavir ) for treatment of HIV, the virus that causes AIDS. The FDA announced the approval in a statement. Fortovase is a new formulation of
Reuters NewMedia, Inc. - Friday November 7 12:10 AM EST
Simona de Logu
RIO DE JANEIRO, Nov 6 (Reuters) - AIDS could become the leading cause of death among adolescents and young adults in Latin America and the Caribbean if prevention programs are not stepped up, international AIDS researchers said on Thursday. Of the more than 22.6 million people in the world estimated to be suffering fro
Reuters NewMedia, Inc. - Thursday November 6 4:49 PM EST
NEW YORK, Nov 6 (Reuters) - An overwhelming number of Americans support lifting a ban on federal government HIV prevention money being spent on needle exchange programs, a drug policy research institute said Thursday. It quoted a public opinion poll conducted last month when U.S. House and U.S. Senate negotiators agree
Reuters NewMedia, Inc. - Monday November 3 11:55 PM EST
WASHINGTON, Nov 4 (Reuters) - Italian scientists confirmed Tuesday what many had already suspected -- that the AIDS epidemic is changing, moving from men to women, and from drug users to their sexual partners. They said their findings, based on statistics from the Rome area, probably applied to other big cities such as
Reuters NewMedia, Inc. - Wednesday October 29 4:54 PM EST
MONROE, Conn., Oct 29 (Reuters) - Hundreds of residents who received flu shots at town-sponsored clinics are worried that they might have been exposed to viruses that cause hepatitis and AIDS, officials said Wednesday. They said many residents lined up for recommended hepatitis B shots on Wednesday after the scare.
Reuters NewMedia, Inc. - Tuesday October 28 8:49 AM EST
Paul Majendie
LONDON (Reuters) - People around the globe are having more sex with the French just edging Americans to become the world s most sexually active nation, according to a survey published on Tuesday. The poll criticized Russians as selfish lovers and said Hong Kong people were often too exhausted by work to bother.
Reuters NewMedia, Inc. - Tuesday October 28 8:07 AM EST
Ruben Alabastro
MANILA (Reuters) - Asian governments came under fire at an AIDS congress in Manila Tuesday for spending billions of dollars on arms but only a trickle to fight a disease that has struck seven million of their people. Throughout our region, governments ... fail to respond properly to HIV/AIDS. The rhetoric may be there.
Reuters NewMedia, Inc. - Monday October 27 3:54 PM EST
Ruben Alabastro
MANILA, Philippines (Reuters) - The world s first mass test of a vaccine against the virus that causes AIDS may be held in Thailand possibly as early as 2000, medical experts at an international AIDS congress said Monday. They said tests would be voluntary and conducted among people most exposed to the danger of acquir
Reuters NewMedia, Inc. - Monday October 27 3:56 PM EST
MAYVILLE, N.Y. (Reuters) - Health officials in western New York said on Monday an HIV-infected man had spread the deadly infection to at least 11 people, some of them unwitting teenagers with whom he traded drugs for sex. A total of 98 people are under investigation for having had sexual contact either directly or via
Reuters NewMedia, Inc. - Sunday October 26, 11:50 PM GMT
Ruben Alabastro
MANILA, Oct 26 (Reuters) - Asia will overtake Africa in a few years as the region worst-hit by the virus that causes AIDS and Asians should not to be lulled into complacency by new drug developments, a U.N. official said. Unless Asia wakes up and tackles the AIDS threat now, the region could suffer a tragedy of histori
Reuters NewMedia, Inc. - Friday October 24 2:46 PM EDT
PORTLAND, Maine, Oct 24 (Reuters) - ImmuCell Corp said Friday it has discontinued development of its CrytoGAM bovine anti-Cryptosporidium immunoglobins due to the difficulty in recruiting patients in its clinical trial. The company said the recruitment problem is due to the impact that new HIV therapies are having on A
Reuters NewMedia, Inc. - Friday October 24 5:05 AM EDT
WASHINGTON, Oct 23 (Reuters) - Researchers said Thursday they had found another natural body chemical that might help suppress the virus that causes AIDS. The new substance is a chemokine -- a molecule that cells use to signal one another. Chemokines are involved in the body s response to infections, and the human immu
Reuters NewMedia, Inc. - Thursday October 23 8:56 PM EDT
Maggie Fox, Health and Science Correspondent
WASHINGTON (Reuters) - U.S. researchers said Thursday they had decided to drop segments of AIDS trials in Africa in which subjects received only placebos and no drugs, but denied they were doing so in response to recent criticism. The trials were designed to see whether drug treatments could stop pregnant women from pa
Reuters NewMedia, Inc. - Friday October 17 12:52 PM EDT
Maggie Fox, Health and Science Correspondent
WASHINGTON (Reuters) - U.S. researchers said on Friday they were starting tests of a new vaccine against the AIDS virus in people and said this one was far superior to earlier failed efforts. Julia Hurwitz and Karen Slobod of St. Jude Children s Research Hospital in Memphis, Tennessee, said the U.S. Food and Drug Admin
Reuters NewMedia, Inc. - Thursday October 16 7:32 AM EDT
MANILA, Oct 16 (Reuters) - Coconut oil could be used in trials to develop a possible cure for AIDS but research funding was needed, organisers of a regional vegetable oil forum said on Thursday. We hope... we can actually persuade the members of the lauric family to put money forward ... so that we can fund these trial
Reuters NewMedia, Inc. - Tuesday October 14 12:46 PM EDT
LOS ANGELES, Oct 14 (Reuters) - Investors rushed Tuesday to buy shares of Cell Genesys Inc following the company s announcement that its experimental gene therapy was successful in killing cells infected with the HIV virus. Cell Genesys said late Monday it was able to genetically alter human immune cells so that they s
Reuters NewMedia, Inc. - Monday October 13 2:52 PM EDT
WILMINGTON, Del., Oct 13 (Reuters) - DuPont Merck Pharmaceutical Co, a joint venture of DuPont Co(DD - news) and Merck and Co Inc (MRK), said Monday Sustiva , its once-daily investigational anti-HIV medicine, has shown significant viral load reduction. The company said this viral load reduction is in patients recei
Reuters NewMedia, Inc. - Monday October 13 6:22 PM EDT
Andrea Orr
LOS ANGELES, Oct 13 (Reuters) - A California biotech company said on Monday it had found a way to genetically alter immune cells so that they sought out and killed other cells infected with the HIV virus. The company, Cell Genesys Inc (CEGE), said its findings offered hope of a new treatment that would not just suppres
Reuters NewMedia, Inc. - Monday October 13 3:28 PM EDT
HAMBURG, Germany (Reuters) - The scientist credited with having co-discovered the virus that causes AIDS told a European conference in Hamburg he believed a proper vaccine was still a long way off. The search is proving more and more difficult because the HIV virus is changing all the time, French researcher Luc Monta
Reuters NewMedia, Inc. - Monday October 13 9:22 AM EDT
CAMBRIDGE, Mass., Oct 13 (Reuters) - Vertex Pharmaceuticals Inc said it had encouraging results from preliminary 12-week data from an ongoing Phase II study of its HIV protease inhibitor, used in a three-drug cocktail. The inhibitor, 141W94 (VX-478), was generally well-tolerated and produced potent antiviral activity,
Reuters NewMedia, Inc. - Monday October 13 6:21 AM EDT
LONDON, Oct 13 (Reuters) - AZT should continue to be included in combination therapy for AIDS and HIV as the only marketed drug proven to show effect against the virus in the brain, Britain s Glaxo Wellcome Plc said on Monday.
Reuters NewMedia, Inc. - Friday October 10 8:01 AM EDT
HANOI, Vietnam (Reuter) - A U.N. group said Friday it had agreed to launch a three-year program to try to brake the spread of HIV/AIDS among drug abusers in Vietnam. HIV/AIDS prevention targeted for urban youth is a pressing mission to be achieved since intravenous drug abuse is spreading among young people in urban ar
Reuters NewMedia, Inc. - Friday October 3 6:19 PM EDT
WASHINGTON, Oct 3 (Reuter) - Dr. William Paul, Director of the Office of AIDS Research at the U.S. National Institutes of Health, said on Friday he had resigned so that he could work on a vaccine against the deadly syndrome. In a letter to associates and journalists, Paul said he was leaving with a true sense of accomp
Reuters NewMedia, Inc. - Thursday October 2 5:36 AM EDT
WASHINGTON (Reuter) - U.S. anti-drug czar Gen. Barry McCaffrey dodged lawmakers calls to campaign against various state laws allowing the medical use of marijuana, saying the American people must decide. At the end of the day, it seems to me ... (that we ll give them) the scientific fact, and let the American people ma
Reuters NewMedia, Inc. - Wednesday October 1 5:23 PM EDT
Maggie Fox, U.S. Health and Science Correspondent
WASHINGTON, Oct 1 (Reuter) - Two studies published on Wednesday found possible new approaches to battling the AIDS virus, and also shed more light on the insidious ways the virus attacks the immune system. Both centered on cytokines -- the immune system signalling chemicals the human immunodeficiency virus (HIV) depend
Reuters NewMedia, Inc. - Monday September 29 3:12 PM EDT
TORONTO (Reuter) - A triple cocktail using the newest class of AIDS drug pushed the HIV virus down to undetectable levels in more than half of patients, researchers told a conference Monday. The combination of nevirapine -- a non-nucleoside reverse transcriptase inhibitor (NNRTI) -- with the older AIDS drugs
Reuters NewMedia, Inc. - Monday September 29 10:34 PM EDT
Andrea Orr
LOS ANGELES (Reuter) - The celebrated AIDS drugs known as protease inhibitors may not be as effective as clinical trials have suggested, according to a new study that finds a high failure rate in real world conditions. Researchers at the University of California said Monday they looked at 136 patients who had taken the
Reuters NewMedia, Inc. - Monday September 29 7:03 PM EDT
WASHINGTON, Sept 29 (Reuter) - Babies who are infected with HIV should be given potent drug combinations as soon as possible to stop the infection from progressing, U.S. officials said on Monday. They said babies at risk should be tested as early as possible so that immediate treatment could begin. The guidelines, prop
Reuters NewMedia, Inc. - Monday September 29 9:06 AM EDT
LA JOLLA, Calif., Sept 29 (Reuter) - Agouron Phamaceuticals Inc said Monday that it will report this week additional studies of VIRACEPT showing that anti-HIV effects from the drug, in combination with other anti-HIV drugs, continue to be observed after 12 months of treatment. These and other results will be reported b
Reuters NewMedia, Inc. - Monday September 29 11:13 AM EDT
David Rosenberg
JERUSALEM, Sept 29 (Reuter) - An Israeli company said on Monday it had been issued a patent for a blood diagnosis device that detects the HIV virus far earlier than conventional methods and could play a key role in limiting the spread of AIDS. Shiloov Medical Technologies Ltd said its ShiloovTube helps detect the prese
Reuters NewMedia, Inc. - Friday September 26 7:20 PM EDT
WASHINGTON, Sept 26 (Reuter) - A new cocktail of drugs including hydroxyurea -- not usually an AIDS drug -- suppressed the HIV virus to undetectable levels in one patient, even after treatment stopped, the journal Science reported on Friday. He seemed to be free of infection nine months after he stopped taking the drug
Reuters NewMedia, Inc. - Monday September 22 3:52 PM EDT
Maggie Fox
WASHINGTON (Reuter) - An international group of doctors said on Monday they were volunteering to try out on themselves a vaccine using the HIV virus that causes deadly AIDS. About 50 members of the International Association of Physicians in AIDS Care have signed up to test for safety the attenuated viral vaccine -- a v
Reuters NewMedia, Inc. - Thursday September 18 11:44 PM EDT
Mike Cooper
ATLANTA (Reuter) - The number of Americans newly diagnosed with AIDS last year dropped 6 percent from the year before, the first decline in the history of the epidemic, federal health officials said Thursday. The Centers for Disease Control and Prevention (CDC) said the number of new AIDS cases reported among teenagers
Reuters NewMedia, Inc. - Thursday September 18 7:37 PM EDT
LONDON, Sept 19 (Reuter) - British AIDS charities on Friday condemned an HIV treatment lottery, saying the quality of care of infected patients should not depend on the area in which they live. Charity officials said some patients were being denied life-prolonging combination drug therapies, others were being prescribe
Reuters NewMedia, Inc. - Tuesday September 16 10:33 PM EDT
CHICAGO (Reuter) - There was a 63 percent increase in the number of women diagnosed with AIDS in the United States from 1991 to 1995, according to a report publishedTuesday. By the end of 1995, 67,400 women had been diagnosed with the disease, almost 20 percent of the total AIDS cases in the United States, the report f
Reuters NewMedia, Inc. - Sunday September 14 12:00 AM EDT
SAN FRANCISCO, Sept 14 (Reuter) - A new formulation of saquinavir , one of the new protease inhibitor drugs that have helped revolutionize AIDS treatment, gives a stronger response than its older drug Invirase , Hoffmann-La Roche (ROCZG.
Reuters NewMedia, Inc. - Thursday September 11 8:48 PM EDT
Maggie Fox, Health and Science Correspondent
WASHINGTON, Sept 11 (Reuter) - A herpes virus that causes an AIDS-associated cancer may act as a kind of molecular spy against its own kind, offering valuable information on how to fight HIV, the virus that causes AIDS, researchers said on Thursday. They said human herpesvirus 8 (HHV-8) had surrendered secrets about ho
Reuters NewMedia, Inc. - Thursday September 11 11:07 AM EDT
Mike Cooper
ATLANTA, Sept 11 (Reuter) - Life expectancy reached an all-time high of 76.1 years in the United States last year, as infant mortality fell to a record low and deaths from AIDS declined, U.S. health officials said on Thursday. In a wide-ranging analysis of preliminary birth and death statistics from 1996, the federal C
Reuters NewMedia, Inc. - Wednesday September 10 6:21 PM EDT
Leslie Gevirtz
BOSTON, Sept 10 (Reuter) - Two studies show conclusively that a triple drug treatment can dramatically reduce the amount of AIDS-causing virus in the blood and lower the risk of death for at least a year. What the studies in Thursday s New England Journal of Medicine did not address was how most of the millions of peop
Reuters NewMedia, Inc. - Thursday September 4 7:23 PM EDT
Gene Emery
BOSTON, Sept 4 (Reuter) - Two teams of scientists reported on Thursday that they had developed two promising ways to ward off the human immunodeficiency virus (HIV), techniques that might one day prevent an AIDS infection from developing. Although the current work is not yet ready for a clinical setting, the research b
Reuters NewMedia, Inc. - Monday September 1 7:31 AM EDT
LONDON, Sept 1 (Reuter) - British biotechnology company KS Biomedix Plc said on Monday it would collaborate with leading French AIDS researcher Luc Montagnier in the search for a treatment for HIV infection and AIDS. In a statement the company said scientists led by Montagnier, who helped to discover the AIDS virus in
Reuters NewMedia, Inc. - Friday August 22 4:45 PM EDT
Michael Becker
KINGSTON, Jamaica (Reuter) - Six inmates were killed in three days of prison riots sparked by a government official s proposal to distribute condoms to inmates and guards, authorities said Friday. Police said two inmates were stabbed and burned to death Friday even as jail guards returned to work at the island s two ma
Reuters NewMedia, Inc. - Friday August 22 4:58 PM EDT
KINGSTON, Jamaica (Reuter) - Four prison inmates have died in rioting sparked by a Jamaican government official s proposal to distribute condoms to prison inmates and guards, a newspaper reported Friday. Danny Coke, an inmate of the St. Catherine District Prison in Spanish Town, west of Kingston, was set on fire and bu
Reuters NewMedia, Inc. - Thursday August 21 12:37 AM EDT
Maggie Fox, Health Correspondent
WASHINGTON (Reuter) - Conservative groups and AIDS activists dueled over the benefits of needle exchange programs Wednesday, but the office of the president s drug czar said focusing on drug treatment was a better way to stem the spread of AIDS. While conservative policy groups maintained that needle exchange programs
Reuters NewMedia, Inc. - Wednesday August 20 11:41 PM EDT
SAN FRANCISCO (Reuter) - A member of Congress said Wednesday she is sponsoring legislation to end a ban on federal funding of needle exchange programs intended to reduce the spread of AIDS among drug users. U.S. Rep. Nancy Pelosi, a California Democrat, said she and Rep. Elijah Cummings, a Maryland Democrat, have intro
Reuters NewMedia, Inc. - Tuesday August 19 4:46 AM EDT
BRUSSELS, Aug 19 (Reuter) - Belgian-based biotechnology firm Innogenetics said it would benefit from an AIDS test licensing deal between Abbott Laboratories (ABT), Boehringer Mannheim (BOHR.NS) and Behring Diagnostics. The deal, financial details of which were not disclosed, gives Abbott the right to use Innogenetics
Reuters NewMedia, Inc. - Thursday August 14 5:01 PM EDT
Deborah Zabarenko
WASHINGTON (Reuter) - A relatively common genetic mutation appears to delay the onset of AIDS for years, researchers reported Thursday. This is the second gene link to people who seem to never get the deadly syndrome despite exposure to it, or who fail to show symptoms of the disease despite testing positive for HIV, t
Reuters NewMedia, Inc. - Wednesday August 13 6:20 PM EDT
BOSTON, Aug 13 (Reuter) - People who risk contracting HIV may be resuming risky practices because they think new treatments have made AIDS less of a health threat, according to a small-scale survey of gay men in San Francisco. Our findings suggest that recent advances in treatment are affecting the sexual decision-maki
Reuters NewMedia, Inc. - Wednesday, 6 August 1997, 10:44 AM EDT
RESEARCH TRIANGLE PARK, N.C., August 6 (Reuter) - Glaxo Wellcome Plc (GLXO.L) said Wednesday it started testing its anti-HIV drug 1592 in a trial that will enroll up to 2,400 adults in 65 U.S. test centers by year end. A Glaxo spokeswoman said the drug is being tested in a so-called open-label trial, whereby all patien
Reuters NewMedia, Inc. - Friday August 1, 1997 - 7:01 AM EDT
WASHINGTON (Reuter) - Spree killer Andrew Cunanan was not infected with the AIDS virus when he killed himself aboard a Miami Beach houseboat last month, according to the Miami Herald newspaper. In its Friday edition, the Herald said three law enforcement sources told them, on condition of anonymity, that tests performe
Reuters NewMedia, Inc. - Friday July 25 9:18 AM EDT
CAMBRIDGE, Mass., July 25 (Reuter) - Hybridon Inc said Friday it had decided to stop further development of its first generation antisense drug, GEM91, based on a preliminary review of new data from a Phase II clinical trial of patients with advanced HIV infection. The company said that in the Phase II trial, three of
Reuters NewMedia, Inc. - Thursday July 24, 1997 8:57 PM EDT
ATLANTA, July 24 (Reuter) - U.S. Federal health officials warned on Thursday that using expensive new AIDS drugs as a morning-after treatment could set back efforts to encourage safe sex and cause the virus that causes AIDS to become more resistant to treatment. Drug therapy, already recommended for health care workers
Reuters NewMedia, Inc. - Thursday July 24, 1997 1:52 PM EDT
NEW YORK (Reuters) -- One way in which HIV brings the immune system to its knees is to continuously activate infection-fighting T cells until they are depleted, thus allowing normally harmless infections to become life-threatening. Now a new study suggests that the virus may promote this process by stimulating infected
Reuters NewMedia, Inc. - Wednesday July 23 11:15 AM EDT
HARARE, Zimbabwe (Reuter) - U.S. delegates at an African-American summit have pledged to press U.S. pharmaceutical companies to make expensive AIDS drugs more accessible to Africa s poor. We will go back home and efforts will be made to make drugs more available by pressuring drug companies to donate drugs to Africa,
Reuters NewMedia, Inc. - Monday July 21 6:01 PM EDT
Ransdell Pierson
NEW YORK, July 21 (Reuter) - Ribozyme Pharmaceuticals Inc said Monday it saw no side effects after administering gene therapy to the first three of five HIV-infected patients in Phase I trials designed to test the treatment s safety. Ribozyme chief executive Ralph Christoffersen said three adult males had been injected
Reuters NewMedia, Inc. - Thursday July 17 1:39 AM EDT
LONDON (Reuter) - Scientists said Wednesday they had found two new receptors that the HIV virus uses to hook onto and infect cells. Naming them Bonzo and BOB (Brother of Bonzo), the researchers said they were used by both the human immunodeficiency virus (HIV) and the version seen in monkeys, SIV. Writing in the scienc
Reuters NewMedia, Inc. - Wednesday July 16 10:28 PM EDT
LONDON, July 16 (Reuter) - Scientists said on Wednesday they had found two new receptors that the HIV virus uses to hook onto and infect cells. Naming them Bonzo and BOB (Brother of Bonzo), the researchers said they were used by both the human immunodeficiency virus (HIV) and the version seen in monkeys, SIV. Writing i
Reuters NewMedia, Inc. - Tuesday July 15 12:45 PM EDT
Ransdell Pierson
NEW YORK, July 15 (Reuter) - Agouron Pharmaceuticals Inc said it was submitting data on Tuesday to the U.S. Food and Drug Administration showing patients with HIV and AIDS who began therapy with a three-drug cocktail earlier in their infections had a greater and more lasting response than those who waited. Peter Jo
Reuters NewMedia, Inc. - Monday, July 14, 1997 16:52:00
Dan Trotta
WASHINGTON (Reuter) - The number of Americans who die from AIDS continues to fall but daunting challenges remain to control the deadly epidemic, a leading group of AIDS experts said Monday. The overall slowing of the epidemic and the impact of effective new drug treatments has led to the lower death rates, but women an
Reuters NewMedia, Inc. - Thursday July 10 5:48 PM EDT
Mike Cooper
ATLANTA (Reuter) - Federal health officials reported Thursday the first documented case in which someone became infected with the AIDS virus by deep kissing an HIV-infected partner whose gums were bleeding. The Centers for Disease Control and Prevention (CDC) said the unidentified woman most likely became infected with
Reuters NewMedia, Inc. - Thursday July 10 6:44 PM EDT
NEW YORK (Reuters) -- The Centers for Disease Control and Prevention (CDC) believe they may have spotted the first case of HIV virus transmission linked to deep-kissing . CDC researchers investigating the HIV infection of a woman whose longtime sexual partner carried the AIDS virus believe the most likely possibility i
WASHINGTON (Reuter) - The Food and Drug Administration Thursday said blood products were being recalled in six states because the donors may have been exposed to a tick-borne disease which could be transmitted through blood transfusions. The blood products were collected by United Blood Services (UBS), also known as Bl
Reuters NewMedia, Inc. - Wednesday July 9 2:46 AM EDT
TOKYO, July 9 (Reuter) - Osaka-based drug maker Green Cross Corp (4522.T) said on Wednesday will market Bristol-Myers Squibb Co s (BMY) HIV drug in Japan . It said it may start selling the drug in Japan by the end of July. Bristol-Myers Squibb KK, the U.S. drug firm s Japanese unit, said in a statement that the drug,
Reuters NewMedia, Inc. - Friday, July 04, 1997 06:01:00
Stephanie Nebehay
GENEVA (Reuter) - Nearly 1.65 million people have been officially reported as having contracted AIDS since the start of the pandemic, an increase of 18 percent from a year ago, the World Health Organisation (WHO) said on Friday. But the United Nations agency estimated the true cumulative number of victims of Acquired I
Reuters NewMedia, Inc. - Thursday July 3 3:06 PM EDT
BOSTON, July 3 (Reuter) - (SARAWAK) MediChem Pharmaceuticals Inc>, of Lemont, Ill., said Friday it had begun screening patients for Phase IA clinicial trial of Calanolide A, an anti-HIV agent. Sarawak said Calanolide A was discovered by scientists of the Arnold Arboretum of Harvard University in the rainforest of Saraw
Reuters NewMedia, Inc. - Thursday July 3 12:39 AM EDT
NEW YORK (Reuter) - Federal regulators warned Johnson & Johnson to clean up its quality control proceedures in the months before the company pulled a controversial home H.I.V. test from the market, The New York Times said. In Thursday s edition, the Times said the company s Direct Access Diagnostics unit said last
Reuters NewMedia, Inc. - Wednesday July 2 3:47 PM EDT
LOS ANGELES, July 2 (Reuter) - Immune Response Corp is optimistic about winning U.S. approval over the next few years for two drugs, each of which has a potential market of over a million patients, President Dennis Carlo said. In an interview, Carlo said he sees a greater than 50 percent chance the company will be able
Reuters NewMedia, Inc. - Friday June 27 10:40 AM EDT
LONDON (Reuter) - A genetic mutation that helps some HIV-infected people resist AIDS causes a quicker death once they do develop the infection, Danish doctors said Friday. Some people have a slightly different version of a cell receptor -- a kind of doorway -- known as CCR5. It is one receptor used by the HIV virus to
Reuters NewMedia, Inc. - Friday June 27 10:57 AM EDT
LONDON (Reuter) - Men suffering from sexually transmitted diseases (STDs) are much more likely to pass on HIV, the virus that causes AIDS, in their semen, a team of international researchers reported Friday. They said infection caused the virus to concentrate -- perhaps because it was preying on the immune system cells
Reuters NewMedia, Inc. - Friday June 27 9:55 AM EDT
BRUSSELS, June 27 (Reuter) - The United Nations on Friday released the following figures as it launched a campaign entitled Children living in a world with AIDS. (HIV is Human Immunodeficiency Virus, the virus that leads to AIDS, or Acquired Immune Deficiency Syndrome). Global estimates on HIV/AIDS at end 1996: Peo
Reuters NewMedia, Inc. - Friday, June 27, 1997 12:50:00
David Fox
BRUSSELS, Belgium (Reuter) - The United Nations warned Friday that Africa was in danger of becoming a continent of orphans unless swift action was taken to control the spread of the deadly virus that leads to AIDS. But Peter Piot, executive director of UNAIDS , the U.N. organization set up to fight Acquired
Reuters NewMedia, Inc. - Thursday June 26 5:24 PM EDT
WASHINGTON, June 26 (Reuter) - A study released on Thursday showed that, as with adults, children infected with HIV benefit more from a combination of drugs than from doses of a single drug. The study, supported by the U.S. National Institutes of Health, involved 596 children aged between 42 days and 15 years at 87 dif
Reuters NewMedia, Inc. - Thursday June 26 7:13 PM EDT
BRIDGEWATER, N.J. (Reuter) - Johnson & Johnson said Thursday it was withdrawing its home HIV test due to lack of consumer demand. After a year on the market, the usage level of Confide is quite low, said Robert Miller, president of Johnson & Johnson s Direct Access Diagnostics unit. Confide was cleared for
Reuters NewMedia, Inc. - Wednesday June 25 10:20 AM EDT
LARNACA, Cyprus June 25 (Reuter) - A Cypriot charged with giving his British lover the deadly AIDS virus on Wednesday admitted to having unprotected sex with her by mistake, but blamed her for his blunder. I insisted on putting on a condom because of my problem but she was against it, Pavlos Georgiou, who is HIV posit
Reuters NewMedia, Inc. - Wednesday, June 25, 1997 04:22:00
SAN FRANCISCO (Reuter) - U.S. mayors called on the federal government to free up funding for controversial needle exchange programs to stem the spread of HIV among intravenous drug users. The resolution, adopted by the U.S. Conference of Mayors at its meeting in San Francisco, urged Secretary of Health and Human Servic
LONDON (Reuter) - A team of international researchers said Friday it had proved, in the largest trial ever of its kind, that a triple combination of drugs can help HIV-infected people live longer. Their trial of 3,500 people in 22 countries showed that starting patients out right away on a triple combination greatly re
Reuters NewMedia, Inc. - Thursday June 19 5:05 PM EDT
Alastair Macdonald
MOSCOW (Reuter) - Have sex, but use a condom was the message to young Muscovites Thursday from the Kremlin, shocked by the realization that Russia is on the verge of a major AIDS epidemic with the infection rate rocketing in the past year. The Safe Sex, My Choice advertising campaign, targeting 15-24 year-olds in the c
Reuters NewMedia, Inc. - Thursday June 19 4:13 PM EDT
Patricia Wilson
WASHINGTON (Reuter) - New treatment guidelines for Americans living with the AIDS virus released Thursday recommended an aggressive three-drug blend as the most effective therapy. The report from a federal task force urged treating patients early with a combination of three anti-viral agents, calling the use of two le
Reuters NewMedia, Inc. - Tuesday June 17 10:59 AM EDT
BELTSVILLE, Md., June 17 (Reuter) - Digene Corp said Tuesday that the Ministry of Health of Mexico has recommended that the Digene HIV RNA test be used for the monitoring of AIDS patients by all reference laboratories in Mexico. According to Digene, its HIV RNA test is able to measure as few as 500 genomes of the HIV v
Reuters NewMedia, Inc. - Thursday June 5 10:51 AM EDT
RICHMOND, Calif., June 5 (Reuter) - LXR Biotechnology Inc said Thursday that it will no longer proceed with U.S. clinical trials of its drug Lexirin in AIDS patients. The company said it is halting the trials because of the increased use, in the past six to nine months, of triple drug therapy to treat HIV-positive pati
Reuters NewMedia, Inc. - Thursday June 5 5:34 PM EDT
Ransdell Pierson
NEW YORK, June 5 (Reuter) - The use of immune modulators as a second line of attack against HIV is likely to be adopted by more drug companies, the chief executive officer of CEL-SCI Corp(HIV - news) told Reuters Thursday. This is the next thing in HIV treatment, said Geert Kersten. The whole AIDS field is beginning to
Reuters NewMedia, Inc. - Tuesday June 3 7:35 AM EDT
LONDON, June 3 (Reuter) - Bristol-Myers Squibb Co said on Tuesday it had acquired worldwide development and marketing rights for two protease inhibitors from Novartis Pharma AG. Bristol said in a statement it would start Phase II clinical trials on one of the drugs, known as BMS-234475 (formerly CGP-61755).
Reuters NewMedia, Inc. - Tuesday June 3 3:26 AM EDT
TOKYO, June 3 (Reuter) - Green Cross Corp said on Tuesday that compensation payments to patients who were infected with the HIV virus through its blood products totalled 13.7 billion yen as of the end of May. The company said in a statement that it settled on May 27 a legal liability suit filed by 118 plaintiffs by agr
Reuters NewMedia, Inc. - Monday June 2 7:00 AM EDT
WASHINGTON (Reuter) - Chimpanzees inoculated with an experimental AIDS vaccine have successfully fought off repeated exposures to the AIDS virus up to a year after they were vaccinated, an American research team has reported, according to Monday s Washington Post. The novel vaccine, which consists of a series of nasal
Reuters NewMedia, Inc. - Wednesday May 28 5:15 PM EDT
NEW HAVEN, Conn., May 28 (Reuter) - Vion Pharmaceuticals Inc said Wednesday that the U.S. Patent and Trademark Office issued a patent covering the method of use of B-L-Fd4C, the company s novel L-2 , 3 -didehydro-dideoxy-5-fluorocytidine nucleoside analog, against HIV. The company said this patent complements an earlie
Reuters NewMedia, Inc. - Wednesday May 28, 1997 7:37 PM EDT
Jonathan Birt
LONDON, May 28 (Reuter) - British drugs group Glaxo Wellcome Plc said on Wednesday its anti-viral drug Valtrex was effective in preventing repeat attacks of genital herpes in people with HIV and AIDS. The company said an international study, involving more than 1,000 individuals carrying the HIV virus, showed Valtrex p
Reuters NewMedia, Inc. - Tuesday May 27, 1997 8:38 PM EDT
SACRAMENTO, Calif, May 27 (Reuter) - A person who tries to infect a sex partner with the AIDS virus could face up to nine years in prison under legislation approved by the California Senate on Tuesday. The Senate approved Rainey s bill on a vote of 24-to-1, sending the measure to the Assembly for review. Senator Richar
Reuters NewMedia, Inc. - Tuesday May 27, 1997 9:13 AM EDT
NEW YORK, May 27 (Reuter) - DuPont Merck s DMP 266 drug, used with Merck and Co Inc s Crixivan , moved the HIV-RNA, or viral load, below the quantification level in 80 percent of patients, data from an initial ongoing Phase II study showed. These patients also achieved CD4 immune cell count elevation averaging 140 cell
Reuters NewMedia, Inc. - Wednesday, 21 May 1997 02:48 PM ET
LONDON (Reuter) - Intense psychological stress such as the death of a loved one could be deadly to people with HIV, the virus that leads to AIDS, Britain s New Scientist magazine reported. Researchers in the United States found that a single episode of stress, if it is sufficiently harrowing, can double the rate at whi
Reuters NewMedia, Inc. - Sunday May 18 4:53 PM EDT
BALTIMORE (Reuter) - Evoking the memory of John F. Kennedy s challenge to Americans to put a man on the moon in the 1960s, President Clinton Sunday promised that the the United States would find an AIDS vaccine within a decade. In a commencement address at Morgan State University, his first of this year s graduation se
Reuters NewMedia, Inc. - Sunday, May 18, 1997 05:35:00 PM
WASHINGTON (Reuter) - President Bill Clinton is expected to set a national goal of finding a vaccine to prevent AIDS by 2007 and will pledge new federal efforts Sunday to make it happen, according to administration officials. Clinton is due to announce his new initiative, likening it to John F. Kennedy s challenge in t
LONDON (Reuter) - AIDS researchers from four continents have published the results of a key study which is changing the way HIV-positive patients are treated. Their report showed that adding a third drug, lamivudine (Glaxo-Wellcome s Epivir ), to anti-AIDS combinations based on Glaxo s
Reuters NewMedia, Inc. - Thursday May 8 11:43 AM EDT
WASHINGTON (Reuter) - The drug cocktails now being used for AIDS patients are proving able to suppress the virus in lymph tissue as well as in their blood, scientists said Thursday. The lymph findings, appearing in the journal Science on Friday, dovetail with numerous studies that have shown the new triple combination
Reuters NewMedia, Inc. - Thursday, May 08, 1997 12:46:00 PM
LONDON (Reuter) - People infected with the HIV virus that causes AIDS received good news and bad news Thursday -- drugs can probably kill off the virus but it will take years. A flurry of studies showed that the cocktail approach using a combination of strong drugs can probably eventually get to every infected cell in
Reuters NewMedia, Inc. - Wednesday May 7 12:56 PM EDT
NEW BRUNSWICK, N.J., May 7 (Reuter) - Interferon Sciences Inc said Wednesday that it has reached the enrollment target of 110 patients in its Phase III, multi-center clinical trial investigating the potential use of ALFERON N Injection for the treatment of HIV-positive patients. The company said that if the results of
Reuters NewMedia, Inc. - Wednesday May 7 5:08 PM EDT
VANCOUVER, Wash., May 7 (Reuter) - Saliva Diagnostic Systems Inc said Wednesday it received regulatory approval in India to market and distribute its rapid HIV testing product in that country. The company said it expects that more than 350,000 Sero *Strip HIV tests will be used in its first year of distribution in Indi
Reuters NewMedia, Inc. - Wednesday May 7 7:26 PM EDT
Gene Emery
BOSTON, May 7 (Reuter) - A new study has confirmed something about babies that doctors already knew about adults: the more HIV there is in the blood, the faster the deadly immunity disease AIDS appears. In tests on 106 newborns infected with HIV, a research team led by Dr. William Shearer of the Baylor College of Medic
Reuters NewMedia, Inc. - Tuesday May 6 10:38 AM EDT
LA JOLLA, Calif., May 6 (Reuter) - Agouron Pharmaceuticals Inc said Tuesday it will start a Canadian Expanded Access Program, which will supply Agouron s HIV protease inhibitor, VIRACEPT in Canada to qualified adults with advanced HIV disease -- without charge. In a statement, the company said a second treatment op
Reuters NewMedia, Inc. - Monday May 5 11:05 AM EDT
ALEXANDRIA, Va., May 5 (Reuter) - CEL-SCI Corp said Monday that its HGP-30 HIV vaccine induced antibodies in humans and in mice that recognize regions of the HIV subtypes B, C and E. The company said that this finding is important because there is substantial variability accompanied by continued mutation between these
Reuters NewMedia, Inc. - Thursday May 1 6:58 PM EDT
Mike Cooper
ATLANTA, May 1 (Reuter) - Women whose partners use condoms to prevent AIDS and other sexually transmitted diseases should not stop taking birth control pills to prevent pregnancy, federal health officials said on Thursday. The U.S. Centers for Disease Control and Prevention (CDC) said a study in five cities found women
WASHINGTON (Reuter) - The immune systems of AIDS patients lose diversity and therapies that fight the virus do not appear to restore the body s full array of disease-fighting cells, researchers said Tuesday. National Institutes of Health scientists report in the journal Nature Medicine that the new AIDS drugs do seem t
Reuters NewMedia, Inc. - Tuesday, April 29, 1997 14:00:00 PM
PHILADELPHIA (Reuter) - Researchers reported Tuesday they had successfully vaccinated two chimpanzees against the virus that causes AIDS, pointing the way to possible use of the technique in humans. The vaccine s effectiveness is unprecedented in a primate species, which, like humans, is susceptible to infection with t
LONDON (Reuter) - The HIV virus that causes AIDS could be getting more aggressive, Italian researchers reported Friday. A study of nearly 300 people infected with HIV showed those infected after 1989 got sicker faster than those infected before, Dr. Allessandro Sinicco and colleagues at the University of Turin said. Th
Reuters NewMedia, Inc. - Wednesday April 23 6:54 PM EDT
BRANCHBURG, N.J., April 23 (Reuter) - Merck and Co Inc said on Wednesday researchers were working on a new combination therapy to fight HIV, the virus that causes AIDS. The new treatment combines Merck s Crixivan , a protease inhibitor, and a compond known as DMP-266, being developed by a DuPont
Reuters NewMedia, Inc. - Tuesday April 22 2:57 PM EDT
NEW YORK -- For the first time scientists have exposed a weak spot in the virus that causes AIDS -- which may lead to new drugs that will keep it from invading and destroying human cells. The discovery is based on high-resolution pictures of an envelope protein fragment on the surface of HIV that the virus uses to get
Reuters NewMedia, Inc. - Friday, April 18, 1997 02:44:00 PM
CAMBRIDGE, Mass. (Reuter) - Researchers said Thursday they had isolated a weak spot in the AIDS virus which may allow new drugs to stop the infection from spreading. Led by Dr. Peter Kim and Dr. David Chan at the Whitehead Laboratory in Cambridge, scientists have isolated an image of the viral protein that allows HIV t
WASHINGTON (Reuter) - The new AIDS drugs are prolonging lives but the federal and state governments will have to do more to make sure all patients get access to them, patients, doctors and activists said Thursday. The AIDS Drug Assistance Program (ADAP) working group estimated that the cost for the next fiscal year wou
Reuters NewMedia, Inc. - Thursday April 17 9:56 AM EDT
FARMINGDALE, N.Y., April 17 (Reuter) - Enzo Biochem Inc said Thursday that it has successfully used gene therapy to produce human immune (CD4+) cells in the laboratory with resistance to repeated challenges by HIV over a prolonged period. Enzo said that the more than year-long study showed that CD4+ monocyte cells, whi
Reuters NewMedia, Inc. - Wednesday April 16 1:06 PM EDT
GLENVIEW, Ill. (Reuter) - An Illinois life insurance company offering first-of-its kind policies to HIV-positive people said Wednesday it was receiving many calls from potential buyers. News of the life insurance policies for HIV carriers offered by Guarantee Trust Life Insurance Co. had created a surge of calls to the
Reuters NewMedia, Inc. - Monday April 14 2:59 PM EDT
RESEARCH TRIANGLE PARK, N.C. April 14 (Reuter) - Glaxo Wellcome Plc GLXO.L said Monday that the Food and Drug Administration has released Epivir ( Lamivudine ) under traditional regulations for use in combination with Retrovir.
Reuters NewMedia, Inc. - Saturday, April 12, 1997 03:33:00 PM
SAN FRANCISCO (Reuter) - A judge has issued a temporary restraining order blocking the federal government from prosecuting doctors who recommend marijuana to their patients. U.S. District Judge Fern Smith of San Francisco also ordered the government Friday to settle through negotiation its dispute with a group of docto
LOS ANGELES (Reuters) - An experimental AIDS drug being developed by Gilead Sciences Inc has been shown to drive down viral levels by more than 90 percent in the first eight days of treatment in clinical trials, the company said Friday. Although Gilead has yet to test the drug for sustained periods of time in humans, i
Reuters NewMedia, Inc. - Friday, April 11, 1997 13:16:00 PM
ST. LOUIS (Reuter) - Health officials in two states, fearing an explosion of AIDS cases, are searching for dozens of women who had sex with a man who was shot to death this year, a newspaper reported Friday. The St. Louis Post-Dispatch said at least 61 girls and women had sex with Darnell McGee in the two years before
FOSTER CITY, Calif., April 11 (Reuter) - Gilead Sciences Inc said Friday that a Phase I/II study showed that intravenous PMPA significantly reduced human immunodeficiency virus RNA levels, a marker of HIV viral load, by greater than 90 percent after eight doses, with no significant side effects. The magnitude of H
WASHINGTON (Reuter) - Two teams of scientists Wednesday reported they had been able to block the AIDS virus from infiltrating and infecting certain blood cells. One team in effect locked the virus out of certain blood cells in a test tube. The other team issued a progress report in a small, novel experiment that entail
GENEVA (Reuter) - Scientists at Geneva University have discovered a new protein which blocks the penetration of the AIDS-causing HIV virus into cells in test tubes, Swiss newspaper Journal de Geneve reported Wednesday. The French-language daily quoted Robin Offord, a scientist at the university s biochemical medicine d
WASHINGTON (Reuter) - President Clinton Monday named Sandra Thurman director of the Office of National AIDS Policy, which coordinates federal policy and programs to combat the disease. Thurman, who worked on Clinton s election campaigns in 1992 and 1996, was executive director of AID Atlanta, which provides health and
Reuters NewMedia, Inc. - Thursday April 3 2:29 PM EST
Rita Farrell
WILMINGTON, Del., April 3 (Reuter) - A U.S. subsidiary of France s Sanofi SOFP.PA , Genetic Systems Corp, has sued United Biomedical Inc of Hauppauge, N.Y., for alleged infringement of a patent for an HIV-2 virus test kit. In papers filed in the U.S. District Court in Delaware, Genetic said it was the exclusive license
Reuters NewMedia, Inc. - Wednesday April 2 3:38 AM EST
SAN FRANCISCO, April 2 (Reuter) - Researchers in California said on Wednesday they had identified cells that suppress the reproduction of HIV and their findings could arm scientists with new weapons in the fight against AIDS. The cells, known as naive CD4 T cells, mount the body s initial response to infections such as
Reuters NewMedia, Inc. - Tuesday March 25, 1997 5:49 PM EST
CHICAGO, March 25 (Reuter) - An anonymous survey of U.S. blood donors found that some lied at the time they gave blood when asked about risky behaviors that made them susceptible to AIDS and other infections, researchers said on Tuesday. Of 35,000 blood donors from five cities who responded to the survey created by Ame
Reuters NewMedia, Inc. - Monday March 24 7:12 PM EST
Maggie Fox, London Newsroom, 44-171-542-8958
LONDON, March 25 (Reuter) - Bristol-Myers Squibb Co said on Tuesday that trials had shown double combination therapy using its Zerit ( stavudine ) drug worked better than those using Glaxo Wellcome s G
Reuters NewMedia, Inc. - Friday March 21 5:37 PM EST
Joelle Diderich
SAO PAULO, March 21 (Reuter) - U.S. drug maker Merck & Co Inc on Friday announced it was ending a controversial AIDS drug trial in Brazil one year ahead of schedule after tests showed it would be ethically improper to continue. The study found patients infected with HIV, the virus that causes AIDS, who took the pro
LONDON (Reuter) - Companies that test AIDS drugs on patients in poor countries should offer them free treatment even after the trials are over, researchers said Friday. A series of commentaries in the British Medical Journal argued that developing countries should not been seen as a source of cheap human guinea pigs.
LONDON (Reuter) - It was known ironically as the gift that keeps on giving -- a sexually transmitted disease that was painful, highly infectious -- and incurable. Fifteen years after genital herpes transformed the sexual habits of singles on the Western dating scene, it remains an excruciating reminder of the perils of
Reuters NewMedia, Inc. - Thursday March 13 6:56 PM EST
NEW YORK (Reuters) -- A unique type of bacteria is the cause of Gulf War syndrome, and the contagion is being passed from veterans to their family members and pets, as well as to doctors and nurses treating the former soldiers, according to a controversial theory from a California researcher. And more: the researcher,
TOKYO (Reuter) - A doctor who was once Japan s top AIDS expert revealed at his negligence trial Monday that he contemplated suicide when he was blamed for a scandal over the use of HIV-tainted blood products on hemophiliacs. In the first session of his court hearings, Takeshi Abe pleaded not guilty to charges of profes
Reuters NewMedia, Inc. - Tuesday March 4 1:30 PM EST
NEW YORK (Reuters) -- As HIV continues its attack on the immune system, it shifts its focus from one type of T cell -- an immune cell that plays a key role in attacking bacteria and foreign invaders -- to another type, a new study suggests. The shift may explain why the body can successfully fight off AIDS for years, b
Reuters NewMedia, Inc. - Monday March 3 12:06 PM EST
NEW YORK (Reuters) -- Calling it an opportunity lost, researchers say that almost 10,000 new cases of HIV infection could have been avoided between 1987 and 1995 if the U.S. had instituted needle exchange programs for intravenous drug users (IDUs). Two researchers -- Dr. Peter Lurie at the Center for AIDS Prevention St
Reuters NewMedia, Inc. - Monday March 3 5:59 PM EST
NEW YORK (Reuters) -- Maintaining healthy levels of a peptide called glutathione may play a pivotal role in slowing the progression of AIDS, researchers say. People with HIV who have lower glutathione levels (also) have a much lower probability of surviving over the course of three years than do people with normal glut
Reuters NewMedia, Inc. - Friday February 28 1:10 PM EST
NEW YORK (Reuters) -- Reports last year that gay men with a certain double gene defect might be protected against HIV infection may be not be accurate, according to new findings. Australian researchers have found an HIV-infected homosexual man with the same DNA mutation, which appears in both copies of the gene for CCR
Reuters NewMedia, Inc. - Thursday February 27 11:34 PM EST
ATLANTA (Reuter) - Deaths from AIDS have begun to decline for the first time, falling 13 percent during the first half of 1996 because people with the disease are living longer, federal health officials said Thursday. The Centers for Disease Control and Prevention (CDC) said the decline in deaths was due to improved tr
Reuters NewMedia, Inc. - Thursday February 27 6:00 PM EST
DENVER, Feb 27 (Reuter) - Ribozyme Pharmaceuticals Inc chief executive officer Ralph Christofferson said on Thursday the company is on target to start clinical trials the first half of this year on a gene therapy approach using ribozymes against HIV. He told the Colorado Bio Investment Conference the approach uses mult
Reuters NewMedia, Inc. - Thursday February 27 5:42 PM EST
NEW YORK (Reuters) -- For the first time since the epidemic began, the number of AIDS-related deaths in the U.S. have fallen when compared with those in the previous year. For the first time, deaths among persons with AIDS have decreased substantially, according to a report issued Thursday by the Centers for Disease Co
Reuters NewMedia, Inc. - Monday February 24 1:15 PM EST
FOSTER CITY, Calif., Feb 24 (Reuter) - Cell Genesys Inc said it plans to expand clinical studies of its AIDS gene therapy, which is currently in Phase II testing. It said the new testing will involve studying a new manufacturing process and conducting a new pilot study designed to enhance the detection of antiviral eff
Reuters NewMedia, Inc. - Monday February 24 12:54 PM EST
NEW YORK (Reuters) -- HIV-negative gay men often adopt a practice of negotiated safety -- that is, an agreement to stop using condoms if both partners agree to practice safe sex with anyone outside the relationship. Now, a new survey of Australian men suggests that homosexual men are indeed less likely to engage in unp
Reuters NewMedia, Inc. - Saturday, February 22, 1997 16:32:00 PM
SAN FRANCISCO (Reuter) - People with HIV -- the virus that causes AIDS -- who have ample levels of a molecule normally found throughout the body, are likely to live longer than patients with low levels, researchers said Saturday. The more of these molecules patients carry in their CD4 T cells -- the primary cells targe
Reuters NewMedia, Inc. - Thursday, February 20, 1997 15:04:00 PM
WASHINGTON (Reuter) - U.S. health experts gave a tentative endorsement Thursday to new research into the medical uses of marijuana. Without making formal recommendations or reaching any firm conclusions following a two-day workshop at the National Institutes of Health, the chairman of the expert panel suggested that so
Reuters NewMedia, Inc. - Thursday, February 20, 1997 11:16:00 PM
WASHINGTON (Reuter) - A homemade bamboo pipe and a set of handcuffs were on display Thursday at a public forum on the future of U.S. research into the medical use of marijuana. I m in a wheelchair already; do you want to see me in jail? Andrew Hassenfeld, who said he smoked marijuana to ease the muscle tension of multi
Reuters NewMedia, Inc. - Wednesday February 19 10:27 AM EST
LA JOLLA, Calif., Feb 19 (Reuter) - Agouron Pharmaceuticals Inc on Wednesday said its European unit has applied to regulators to sell its anti-HIV drug Viracept in Europe. The filing, called a marketing authorization application, was made to the European Medicines Evaluation Agency, the company said in a sta
Reuters NewMedia, Inc. - Wednesday February 19 7:10 AM EST
WASHINGTON (Reuter) - Federal health officials have endorsed needle exchange programs for drug users to combat AIDS at the community level but did not seek a federally-funded national program. Needle exchange programs can be an effective component of a comprehensive strategy to prevent HIV and other blood-borne infecti
Reuters NewMedia, Inc. - Tuesday, February 18, 1997 09:26:00 PM
NEW YORK (Reuter) -- The United States Tennis Association reportedly has reversed a previous decision and will name the new tennis facility being built for the U.S. Open in honor of Arthur Ashe. The New York Daily News reported Tuesday that the facility in Flushing, N.Y., will be named Arthur Ashe Stadium in honor of t
Reuters NewMedia, Inc. - Monday February 17 2:27 PM EST
NEW YORK (Reuters) -- Experts say home self-testing kits for the presence of the AIDS virus are just as accurate as clinic-based tests. Home collection kits can provide a safe and effective alternative to conventional HIV testing and counseling, say researchers from the Illinois Masonic Medical Center in Chicago, who c
Reuters NewMedia, Inc. - Thursday, February 13, 1997 17:54:00 PM
WASHINGTON (Reuter) - An independent panel of health experts Thursday called for changes in the Clinton administration s AIDS policy, including the introduction of controversial needle exchange programs. AIDS is a preventable disease and the behavior placing the public health at greatest risk may be occurring in legisl
Reuters NewMedia, Inc. - Thursday February 13 10:52 AM EST
EMERYVILLE, Calif., Feb. 13 (Reuter) - Chiron Corp on Wednesday said it and Green Cross Corp 4522.T have agreed to expand human clinical studies of their immunotherapeutic HIV-IT(V). Green Cross, based in Osaka, Japan , will provide an additional $4 million this year to conduct Phase II trials that use HIV-IT(V) in com
LONDON (Reuter) - AIDS patients may be living longer than before but their chances after five years are still slim, British researchers reported Friday. However new drugs and combination treatments introduced in the past two years offered much more hope and could transform such depressing figures. Andrew Phillips of Lo
Reuters NewMedia, Inc. - Wednesday, 5 February 1997 - (Embargoed for 5 p.m. EST)
Gene Emery
BOSTON, (Reuter) - A new survey of more than 100 doctors who regularly care for people with HIV -- the virus that causes AIDS -- has found that more than half have helped patients asking to commit suicide. The number of doctors going along with the practice seems to be increasing, according to the study in Thursday s e
SYDNEY, Australia (Reuter) - The rapid spread of HIV in the Asia Pacific threatens to exacerbate an existing epidemic of tuberculosis (TB) in the region, the World Health Organization (WHO) warned Monday. Asia is already home to about two-thirds of the world s active cases of TB, an airborne lung disease that claims ab
BEIJING, Jan 31 (Reuter) - The number of cases of AIDS infection reported in China s Guangdong province rose 25 percent in 1996 as sexual disease ran rampant through the booming southern region, the Xinhua news agency said. Guangdong last year reported 54 cases of infection with HIV, the virus that causes Acquired Immu
LONDON (Reuter) - A rapid rise in cases of AIDS among heterosexuals in the Third World may be due to HIV infection among paid donors of blood plasma, researchers said Friday. People who donate blood plasma can catch HIV, the infection that causes AIDS, from contaminated equipment and then transmit it to recipients of f
Reuters NewMedia, Inc. - Wednesday January 29 5:57 PM EST
WARREN, N.J., Jan 29 (Reuter) - Celgene Corp on Wednesday said it would file a new drug application for the use of thalidomide to treat wasting in HIV patients. Preliminary review of the data appears very positive, showing statistically significant weight gain, said John Jackson, chairman and chief executive officer, i
Reuters NewMedia, Inc. - Monday January 27 8:26 AM EST
WASHINGTON, Jan 27 (Reuter) - Vertex Pharmaceuticals Inc said preliminary data from a four-week clinical study show that resistance did not develop to 141W94/VX-478 HIV protease inhibitor administered as a single agent over that time period. Vertex said it designed the 141W94/VX-478 inhibitor and it is in development i
Reuters NewMedia, Inc. - Monday January 27 1:10 PM EST
NEW YORK (Reuters) -- A variation in a gene responsible for a certain protein may help to identify people who are at increased risk for HIV infection, a study suggests. People with the variant genes also tend to have a shorter survival time once diagnosed with AIDS, Danish researchers say. Those who inherit the variant
Reuters NewMedia, Inc. - Monday January 27 6:34 PM EST
NEW YORK (Reuters) -- The good news is that combination drug therapy appears to be prolonging survival in AIDS patients, according to reports from an international AIDS conference that ended in Washington on Sunday. The bad news, however, is that the drugs aren t successful in every patient, tending to show the most pr
Reuters NewMedia, Inc. - Sunday, January 26, 1997 11:48:00 PM
Joanne Kenen
WASHINGTON (Reuter) - Aggressive new AIDS treatments can partly repair the damaged immune systems of patients, according to sophisticated new analysis of immune cells, researchers said Sunday. Since the new combination therapies have become available, researchers have known that the drugs can suppress the HIV virus tha
Reuters NewMedia, Inc. - Sunday January 26 12:09 PM EST
LONDON, Jan 26 (Reuter) - U.S.-based Vertex Pharmaceuticals Inc on Sunday claimed fresh progress in the treatment of the HIV virus that causes AIDS with a therapy using a combination of drugs. After trials on seven patients of a new combination therapy being carried out by Glax
WASHINGTON (Reuter) - The death rate for AIDS in New York City dropped by a striking 30 percent last year in what public health officials on Friday called a likely harbinger of a national trend. But that encouraging news was tempered by more evidence that the epidemic is raging in some segments of the population includ
Reuters NewMedia, Inc. - Thursday January 23 8:04 PM EST
WASHINGTON, Jan 23 (Reuter) - Hoffmann-La Roche ROCZg.S said Thursday that early data showed its Invirase ( saquinavir ) AIDS drug interacted favorably with Agouron Pharmaceuticals Inc
Reuters NewMedia, Inc. - Thursday January 23 8:53 PM EST
Andrea Orr
LOS ANGELES, Jan 23 (Reuter) - A new AIDS drug awaiting approval by the Food and Drug Administration offers hope to patients who have failed to respond to other therapies, according to data disclosed Thursday. San Diego-based Agouron Pharmaceuticals Inc said its protease inhibitor,
Reuters NewMedia, Inc. - Thursday January 23 3:30 PM EST
CHICAGO, Jan 23 (Reuter) - Abbott Laboratories Inc said Thursday it filed with the U.S. Food and Drug Administration for expanded labeling for its drug, Norvir , to cover treatment of children with HIV and AIDS. The drug and healthcare products company said there are no drugs in Norvir s class, known as
Reuters NewMedia, Inc. - Thursday January 23 3:17 PM EST
LOS ANGELES, Jan 23 (Reuter) - Agouron Pharmaceuticals Inc is optimistic that the U.S. Food and Drug Administration will approve its Viracept AIDS drug, President and Chief Executive Officer Peter Johnson said on Thursday. Johnson said he expected the FDA to rule on its appl
Reuters NewMedia, Inc. - Wednesday January 22 7:13 PM EST
NEW YORK, Jan 22 (Reuter) - Sheffield Medical Technologies Inc said on Wednesday that French researchers whose work it funds published a study linking certain antibodies to higher resistance to AIDS. Jean-Claude Chermann and two associates wrote an article in AIDS Science indicating that antibodies directed against an
Reuters NewMedia, Inc. - Wednesday, 22 January 1997.
Joanne Kenen
WASHINGTON (Reuter) - AIDS researchers gathered Wednesday for a major conference to see how promising new therapies are living up to high hopes and to try to chart the next steps in the fight against the deadly virus. A year ago, when scientists gathered for this annual meeting, few people outside the field had heard o
Reuters NewMedia, Inc. - Wednesday, January 22, 1997 04:20:00 PM
SAUDATTI, India (Reuter) - Frenzied worshipers gathered near a south Indian temple on Wednesday ready for the full moon celebration of a Hindu goddess whose devotees include a cult sentencing children to a life of prostitution. Girls -- many under 10 years old -- chosen to become Devadasis, meaning handmaidens of god,
Reuters NewMedia, Inc. - Monday January 20 12:02 AM EST
NEW YORK, Jan 19 (Reuter) - A new drug for AIDS patients, 1592, manufactured by Glaxo Wellcome Plc, would be among others receiving attention at this week s AIDS convention in Washington, said Barron s columnist Alan Abelson. In his Up & Down Wall Street column, Abelson wrote that 1592 has been described as a chem
Reuters NewMedia, Inc. - Monday January 20 8:10 AM EST
BASLE, Switzerland , Jan 20 (Reuter) - Roche Holding AG ROCZg.S said it concluded a marketing agreement with Agouron Pharmaceuticals Inc of the U.S. covering Viracept , an anti-HIV drug co-developed by Agouron and Japan Tobacco Inc 2914.
Reuters NewMedia, Inc. - Monday January 20 1:36 PM EST
FOSTER CITY, Calif., Jan. 20 (Reuter) - Gilead Sciences Inc on Thursday said patient enrollment has started in a Phase III trial of GS840 (adefovir dipivoxil) for fighting HIV. The trial is being conducted at the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA), which is sponsored by the National In
Reuters NewMedia, Inc. - Monday January 20 4:54 PM EST
Andrea Orr
LOS ANGELES (Reuter) - AIDS researchers who made a breakthrough by combining three drugs into a highly effective cocktail treatment are now looking at a two-drug mix they say could be an even more potent attack on the virus. Unlike the three-drug cocktail, which works by striking the virus at different junctures in its
Reuters NewMedia, Inc. - Friday January 17 10:42 AM EST
NEW YORK, Jan 17 (Reuter) - Triangle Pharmaceuticals Inc said Friday that preliminary clinical data on its MKC-442 anti-HIV drug showed it produced a significant reduction of HIV in the blood. The data comes from an ongoing trial designed to evaluate the safety and efficacy of repeated multiple oral doses of MKC-442 in
Reuters NewMedia, Inc. - Friday January 17 12:17 PM EST
NEW YORK (Reuters) -- A new study in mice suggests that large doses of AZT given during pregnancy can increase an offspring s cancer risk, but a National Institute of Health (NIH) panel voted this week to make no major changes in treatment recommendations. Whatever cancer risk is involved, it s not as great a risk
Reuters NewMedia, Inc. - Tuesday January 14, 1997 5:26 PM EST
NEW YORK (Reuters) -- An improved HIV saliva test is a highly accurate alternative to blood-sample testing for detecting the virus that causes AIDS, a new study suggests. For more than a decade, researchers have know that the saliva of infected individuals contains low levels of HIV antibodies, but enzymes in saliva al
Reuters NewMedia, Inc. - Monday January 13 12:43 PM EST
NEW YORK (Reuters) -- More than half of all HIV-infected women may develop cervical cancer, and nearly three quarters of those may have evidence of the disease before they are ever diagnosed with HIV, according to a new study. Unlike their male counterparts who suffer from high rates of the skin cancer known as Kaposi
Reuters NewMedia, Inc. - Friday January 10 1:00 PM EST
CAMBRIDGE, Mass., Jan 10 (Reuter) - Vertex Pharmaceuticals Inc said Friday partner Glaxo Wellcome Plc GLXO.L has begun Phase II trials of HIV protease inhibitor 141W94/VX-478 in combination with other HIV protease inhibitors . The 24-week study will involve about 48 HIV-positive adults, and is being conducted at
WASHINGTON (Reuter) - Patterns in the immune system that appear soon after infection with the virus that causes AIDS may predict how the disease will progress, scientists said Thursday. Understanding how the human immunodeficiency virus, or HIV, and the human immune system interact is crucial to efforts to develop a va
Reuters NewMedia, Inc. - Wednesday, 8 January 1997.
VANCOUVER, British Columbia (Reuter) - New AIDS drugs have cut the death rate among patients in British Columbia dramatically, according to data released on Tuesday. In the last three months of 1996, the death rate among British Columbia AIDS sufferers fell to 23 per 1,000 from 70 per 1,000 at the begininng of 1994, sa
NEW YORK (Reuter) - Almost all Americans believe public health programs are important but few understand that they focus on preventing disease and promoting health, according to an opinion poll released Monday. The Harris Poll found that only 1 percent of respondents said public health concerned health education or hea
CHICAGO (Reuter) - Half of all Americans support the right to assisted suicide but only 14 percent would choose it, a survey released by the American Medical Association said Monday. This survey reinforces our belief that once informed of their available options and rights at the end of life, most patients would opt fo
BEIJING, Jan 7 (Reuter) - China vowed on Tuesday to intensify a crackdown on fake and substandard medicine this year in a move that follows the sale of HIV-tainted blood serum. The central government will scrutinise medicine quality more thoroughly this year to ensure public safety, the China Daily said, quoting Shao M
BEIJING (Reuter) - China issued tough new rules on the handling of blood products Sunday in a move that follows the sale of HIV-tainted blood serum. The official Xinhua news agency said the rules covered the production and distribution of blood products and set strict supervisory standards throughout the health industr
This information is designed to support, not replace, the relationship that exists between you and your doctor.